Miao et al. showed that NOTCH1 restores the cell cycle deficiency in BRCA1-mutated triple-negative breast cancer through ATR/CHK1 signaling (Miao et al., 2020). Here, NOTCH1 is linked to triple-negative breast carcinoma.